BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25888626)

  • 1. MET receptor is a potential therapeutic target in high grade cervical cancer.
    Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
    Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.
    Miekus K; Lukasiewicz E; Jarocha D; Sekula M; Drabik G; Majka M
    Cell Death Dis; 2013 Jan; 4(1):e459. PubMed ID: 23328666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo.
    Sekuła M; Miekus K; Majka M
    Int J Oncol; 2014 Jun; 44(6):1853-60. PubMed ID: 24728301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
    Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
    Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Tyszka-Czochara M; Lasota M; Majka M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
    Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX; Lu BB; Yang JS; Wang KM; De W
    J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
    Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
    Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
    Long IS; Han K; Li M; Shirasawa S; Sasazuki T; Johnston M; Tsao MS
    Mol Cancer Res; 2003 Mar; 1(5):393-401. PubMed ID: 12651912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
    Kim B; Park B
    Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 17. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
    Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
    Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
    Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.